Christoph Westphal, M.D., Ph.D., CEO and co-founder of Sirtris Pharmaceuticals, will preside over the opening bell. He will be joined by members of the Sirtris management team including Garen Bohlin, Chief Operating Officer, Peter Elliot, Ph.D., SVP Development, Michael Jirousek, Ph.D., SVP Research, Paul Brannelly, VP Finance, Michelle Dipp, M.D., Ph.D., Director of Corporate Development, and David Sinclair, Ph.D., co-founder and member of the Board of Directors of Sirtris.
